Press Release Header.png

SPORTS MEDICINE TECHNOLOGY COMPANY, IMPELLIA AND UNIVERSITY OF MICHIGAN ATHLETICS ENTER

UNIQUE PARTNERSHIP TO PUSH THE LIMITS OF INNOVATION IN SPORTS MEDICINE

UNIVERSITY OF MICHIGAN ATHLETICS TO UTILIZE IMPELLIA TECHNOLOGIES TO OPTIMIZE ATHLETIC PERFORMANCE AND TO ENHANCE SPORTS-RELATED INJURY PREVENTION & RECOVERY FOR 900+ STUDENT-ATHLETES

For Immediate Release

January 31, 2017

 Ann Arbor, MI – Sports medicine technology company, Impellia and the University of Michigan Athletics Department have entered a unique partnership to push the limits of innovation in sports medicine and performance. U-M Athletics will utilize Impellia’s existing and future portfolio of software and sensor-based sports technologies, with the goal of optimizing athletic performance and enhancing sports-related injury prevention & recovery techniques for its 900+ student-athletes.

 U-M Athletics is exploring a wide-scale implementation of Impellia technologies, in conjunction with their 31 NCAA Division I sports teams, including coaches and Student-Athlete Health & Welfare personnel to keep their student-athletes healthy and playing at their peak levels.

 The University of Michigan is committed to providing student-athletes with the most advanced tools that will allow them to maintain optimal health while performing at their peak levels,” said Darryl Conway, Senior Associate Athletic Director for Student Health & Welfare. “Specialized technologies are increasingly significant in these areas and we are pleased to partner with Impellia on innovative and groundbreaking technologies for the benefit of our students.”

 “We’re excited about the opportunities this mutually-beneficial endeavor will present,” said Charlie Batch, Impellia co-founder and former NFL quarterback. “The core of Impellia’s mission is to play a significant role in the future of sports medicine technologies and their impact on player health, and this partnership presents us with a concrete opportunity to do just that.”

 Impellia and U-M Athletics will work together to analyze product data & feedback, identify best practices, and study data that will inspire product enhancements and will present potential opportunities for the adoption or licensing of Impellia products for U-M sports teams, sports medicine departments and athletic training staffs.

 “This unique relationship with the U-M Athletic Department allows us to gain valuable, first-rate feedback on our portfolio of sports medicine technologies from a wide range of athletic contexts and activities,” said Richard Walker, Impellia co-founder. “We will have the unique ability to collect useful data, both from popular team sports and from individualized Olympic-type athletics.”

 The Impellia - U-M Athletics partnership extends beyond sports, as Impellia is currently conducting sponsored research at the U-M School of Kinesiology Michigan Performance Research Laboratory on its mobile gait assessment product, StrikeFoot.

 “With Impellia’s StrikeFoot technology, we’re able to enhance our research by measuring an individual’s foot movement, pressure center and stability outside the laboratory without compromising the quality of the data,” said Jessica Deneweth Zendler, Ph.D., U-M Assistant Research Scientist and Director of the Michigan Performance Research Laboratory. “This allows us to understand how the student-athlete moves in their natural environment and to track how this movement changes over the course of a season, which will give us better insight into their injury risk and allow the implementation of unique and specialized preventive care systems and programs.”

 Impellia recently participated in the inaugural University of Michigan Exercise & Sport Science Initiative (ESSI) Symposium, with Batch sitting on the ‘Data Science & Analytics’ panel. ESSI is a new U-M research program that draws on experts from a wide range of faculty and students across campus, Michigan Athletics and industry partners to optimize physical performance and health for athletes and exercisers of all ages and abilities. ESSI builds on the work of more than 100 faculty and student researchers from diverse disciplines such as kinesiology, medicine, bioengineering, psychology, nutrition, social sciences and data science, who partner with industry and government on projects that address physical activity and human performance across the lifespan.

 Impellia is a sports technology company focusing on injury prevention, rehabilitation and performance optimization. Impellia provides a suite of individualized, scientifically-validated software and wearable technologies that intersect sports medicine and digital health to deliver a real and sustainable impact on the health of everyone - from elite athletes to everyday people.

 ADDITIONAL NEWS ABOUT IMPELLIA:

REHAB TIME IN NFL LEADS BATCH TO ROLE IN MEDICAL TECH FIRM

http://www.sportsbusinessdaily.com/Journal/Issues/2016/05/02/Marketing-and-Sponsorship/Company-Watch-Impellia.aspx

FORMER NFL QUARTERBACK CHARLIE BATCH HELPS LAUNCH SPORTS REHAB-FOCUSED STARTUP

http://www.geekwire.com/2016/charlie-batch-startup/

HOW CHARLIE BATCH WENT FROM NFL QB TO SPORTS MEDICINE ENTREPRENEUR

http://www.foxbusiness.com/features/2016/03/03/how-charlie-batch-went-from-nfl-qb-to-sports-medicine-entrepreneur.html

 For media inquiries about Impellia, contact Risa Balayem, risa@impellia.co. For business inquiries, contact Richard Walker at rwalker@impellia.co.

 ###